Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized study of omiganan 1.75% topical gel versus vehicle and ketoconazole in mild to moderate facial seborrheic dermatitis
2017-003106-41Phase 2Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Aug 2018
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of omiganan in seborrheic dermatitis (SD) (3 arms), sponsored by Maruho Co., Ltd. Primary endpoint: Pharmacodynamic endpoints. Started Aug 2018; status: completed.
02
Drugs
omiganan
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on 2017-003106-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003106-41.